Mammoth Biosciences

Mammoth Biosciences

Biotechnology Research

Brisbane, California 49,540 followers

Improving lives by reading and writing the code of life.

About us

Mammoth Biosciences is a biotechnology company focused on leveraging its proprietary ultracompact CRISPR systems to develop long-term curative therapies, as well as other applications such as decentralized precision diagnostics. Founded by CRISPR pioneer and Nobel laureate Jennifer Doudna and Trevor Martin, Janice Chen, and Lucas Harrington, the company’s ultracompact proteins are designed to enable in vivo gene editing in difficult to reach tissues utilizing both nuclease applications and new editing modalities beyond double stranded breaks, including base editing, gene writing, and epigenetic editing. The company is building out its pipeline of potential in vivo gene editing therapeutics and capabilities and has partnerships with leading pharmaceutical and biotechnology companies to broaden the reach of its innovative and proprietary technology. Mammoth’s deep science and industry experience, along with a robust and differentiated intellectual property portfolio, have enabled the company to further its mission to transform the lives of patients and deliver on the full promise of CRISPR technologies.

Website
http://www.mammoth.bio
Industry
Biotechnology Research
Company size
51-200 employees
Headquarters
Brisbane, California
Type
Privately Held
Founded
2017

Locations

  • Primary

    1000 Marina Blvd

    Suite 600

    Brisbane, California 94005, US

    Get directions

Employees at Mammoth Biosciences

Updates

Similar pages

Browse jobs

Funding